Doctors say they have achieved the previously impossible - restoring sight and preventing blindness in people with a rare but dangerous eye conditon called hypotony. Moorfields hospital in London is ...

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco for the industry's biggest investor event of the year. Monday, we'll be ...

So good afternoon, everybody. I'm Chris Schott from JPMorgan. And it's my pleasure to be introducing Amgen today. From the company, we have Chairman and CEO, Bob Bradway. Bob, Happy New Year, and ...

LIB Therapeutics secured a green light for its lipid-lowering PCSK9-blocking lerodalcibep in the US, for the treatment of adults with hypercholesterolemia. Lerodalcibep is the first adnectin-based ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...